Craft

Cyanotech

Stock Price

$0.8

2024-10-29

Market Capitalization

$5.4 M

2024-10-29

Revenue

$23.1 M

FY, 2024

Cyanotech Summary

Company Summary

Overview
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition market worldwide. The Company's products include Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids; and Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health. Cyanotech Corporation sells its products in bulk quantities to manufacturers, formulators, and distributors in the health foods and nutritional supplements markets; and as packaged consumer products to distributors, retailers, and direct consumers.
Type
Public
Status
Active
Founded
1983
HQ
Kailua-Kona, HI, US | view all locations
Website
https://www.cyanotech.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Gerald R. Cysewski

    Gerald R. Cysewski, Chief Executive Officer, Founder, Vice Chairman

    • Glenn Jensen

      Glenn Jensen, Vice President – Operations

      • Jen Johansen

        Jen Johansen, Vice President - Quality, Regulatory & Government Affairs

        • Amy Nordin

          Amy Nordin, Vice President - Human Resources, Secretary

          LocationsView all

          1 location detected

          • Kailua-Kona, HI HQ

            United States

            73-4460 Queen Ka'ahumanu Hwy #102Kailua

          Cyanotech Financials

          Summary Financials

          Revenue (Q2, 2025)
          $7.0M
          Gross profit (Q2, 2025)
          $2.4M
          Net income (Q2, 2025)
          $1.0K
          Cash (Q2, 2025)
          $649.0K
          EBIT (Q2, 2025)
          $190.0K
          Enterprise value
          $9.8M

          Footer menu